3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Leukemia, Myeloid, Acute
14
Hodgkin Disease
13
Multiple Myeloma
11
Lymphoma, Mantle-Cell
11
Myelodysplastic Syndromes
10
Lymphoma, Non-Hodgkin
10
Lymphoma, Large B-Cell, Diffuse
10
Leukemia, Prolymphocytic
9
Waldenstrom Macroglobulinemia
8
Myeloproliferative Disorders
8
Leukemia, Myeloid, Chronic-Phase
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Myelodysplastic-Myeloproliferative Diseases
7
Lymphoma, Follicular
6
Lymphoma, B-Cell, Marginal Zone
6
Leukemia, Myelomonocytic, Chronic
6
Burkitt Lymphoma
6
Lymphoma
5
Primary Myelofibrosis
4
Lymphoma, Large-Cell, Immunoblastic
4
Leukemia, Prolymphocytic, T-Cell
4
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
4
Leukemia
4
Hematologic Neoplasms
4
Graft vs Host Disease
4
Blast Crisis
4
Anemia, Refractory, with Excess of Blasts
4
Sezary Syndrome
3
Interventions
Sunitinib
64
Nivolumab
42
pembrolizumab
36
Bevacizumab
32
Everolimus
31
Sorafenib
25
pazopanib
23
Axitinib
23
cabozantinib
14
aldesleukin
13
Ipilimumab
13
temsirolimus
11
Interferon alpha-2
11
Cyclophosphamide
10
avelumab
9
Magnetic Resonance Spectroscopy
9
Interleukin-2
9
lenvatinib
8
atezolizumab
8
Radiosurgery
8
Gemcitabine
8
Immunoglobulin G
7
Erlotinib Hydrochloride
7
Disulfides
6
fludarabine phosphate
5
Radiotherapy
5
Fluorodeoxyglucose F18
5
peginterferon alfa-2b
4
Vorinostat
4
Tyrosine Kinase Inhibitors
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Renal Cell
×
Cyclosporins
×
Clear all
No trials found.